Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Aptose Biosciences Inc. (T.APS) had Weighted-Average Shares Outstanding (Diluted) of 2.55M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-10.47M |
|
-- |
|
-- |
|
-- |
|
-9.85M |
|
-- |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-10.47M |
|
-9.85M |
|
-9.85M |
|
2.55M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
2.55M |
-4.10 |
|
-4.10 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.71M |
|
-- |
|
-- |
|
-- |
|
62.29M |
|
-47.57M |
|
-47.57M |
|
-47.57M |
|
2.55M |
|
| Cash Flow Statement Financials | |
-8.01M |
|
-- |
|
8.03M |
|
5.62M |
|
5.63M |
|
0.01M |
|
0.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.55 |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
22.02% |
|
22.02% |
|
-71.19% |
|
22.02% |
|
-18.64 |
|
-3.14 |
|
-3.14 |
|